Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Protilo SF is a sugar-free nutritional supplement powder developed and marketed by Prisure Medicare, an Indian pharmaceutical company. It is formulated as a blend of whey protein concentrate, maltodextrin, colostrum, docosahexaenoic acid (DHA), omega-3 fatty acids, and essential vitamins and minerals. Designed for oral administration, it aims to support daily nutritional balance, manage dietary deficiencies, enhance immune function, support bone health, and improve overall energy and stamina. The "SF" designation indicates a sugar-free formulation, making it suitable for individuals requiring sugar-restricted diets, such as those with diabetes or those monitoring sugar intake. It is available in flavors such as Chocolate and Kesar and is intended for use across various age groups, including children, adults, and the elderly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Protilo SF.